Suppr超能文献

冠状病毒感染和新冠肺炎期间天然免疫在保护及发病机制中的作用

Innate Immunity in Protection and Pathogenesis During Coronavirus Infections and COVID-19.

作者信息

Malireddi R K Subbarao, Sharma Bhesh Raj, Kanneganti Thirumala-Devi

机构信息

Department of Immunology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA; email:

出版信息

Annu Rev Immunol. 2024 Jun;42(1):615-645. doi: 10.1146/annurev-immunol-083122-043545.

Abstract

The COVID-19 pandemic was caused by the recently emerged β-coronavirus SARS-CoV-2. SARS-CoV-2 has had a catastrophic impact, resulting in nearly 7 million fatalities worldwide to date. The innate immune system is the first line of defense against infections, including the detection and response to SARS-CoV-2. Here, we discuss the innate immune mechanisms that sense coronaviruses, with a focus on SARS-CoV-2 infection and how these protective responses can become detrimental in severe cases of COVID-19, contributing to cytokine storm, inflammation, long-COVID, and other complications. We also highlight the complex cross talk among cytokines and the cellular components of the innate immune system, which can aid in viral clearance but also contribute to inflammatory cell death, cytokine storm, and organ damage in severe COVID-19 pathogenesis. Furthermore, we discuss how SARS-CoV-2 evades key protective innate immune mechanisms to enhance its virulence and pathogenicity, as well as how innate immunity can be therapeutically targeted as part of the vaccination and treatment strategy. Overall, we highlight how a comprehensive understanding of innate immune mechanisms has been crucial in the fight against SARS-CoV-2 infections and the development of novel host-directed immunotherapeutic strategies for various diseases.

摘要

新冠疫情由最近出现的β冠状病毒严重急性呼吸综合征冠状病毒2(SARS-CoV-2)引起。SARS-CoV-2造成了灾难性影响,截至目前已导致全球近700万人死亡。先天免疫系统是抵御感染的第一道防线,包括对SARS-CoV-2的检测和反应。在此,我们讨论感知冠状病毒的先天免疫机制,重点关注SARS-CoV-2感染以及这些保护性反应在重症新冠病例中如何变得有害,进而导致细胞因子风暴、炎症、新冠后综合征及其他并发症。我们还强调了细胞因子与先天免疫系统细胞成分之间复杂的相互作用,这有助于病毒清除,但在重症新冠发病机制中也会导致炎症性细胞死亡、细胞因子风暴和器官损伤。此外,我们讨论了SARS-CoV-2如何规避关键的保护性先天免疫机制以增强其毒力和致病性,以及如何将先天免疫作为疫苗接种和治疗策略的一部分进行治疗性靶向。总体而言,我们强调全面了解先天免疫机制在抗击SARS-CoV-2感染以及开发针对各种疾病的新型宿主导向免疫治疗策略方面至关重要。

相似文献

1
Innate Immunity in Protection and Pathogenesis During Coronavirus Infections and COVID-19.
Annu Rev Immunol. 2024 Jun;42(1):615-645. doi: 10.1146/annurev-immunol-083122-043545.
2
Innate immune evasion by SARS-CoV-2: Comparison with SARS-CoV.
Rev Med Virol. 2020 Nov;30(6):1-9. doi: 10.1002/rmv.2135. Epub 2020 Jul 30.
3
Coronaviruses: Innate Immunity, Inflammasome Activation, Inflammatory Cell Death, and Cytokines.
Trends Immunol. 2020 Dec;41(12):1083-1099. doi: 10.1016/j.it.2020.10.005. Epub 2020 Oct 15.
4
Innate immunity, cytokine storm, and inflammatory cell death in COVID-19.
J Transl Med. 2022 Nov 22;20(1):542. doi: 10.1186/s12967-022-03767-z.
5
RNA Viruses, Toll-Like Receptors, and Cytokines: The Perfect Storm?
J Innate Immun. 2025;17(1):126-153. doi: 10.1159/000543608. Epub 2025 Jan 16.
6
Covid-19: Perspectives on Innate Immune Evasion.
Front Immunol. 2020 Sep 30;11:580641. doi: 10.3389/fimmu.2020.580641. eCollection 2020.
7
COVID-19: Perspectives on innate immune evasion.
Prog Mol Biol Transl Sci. 2025;213:171-214. doi: 10.1016/bs.pmbts.2024.03.002. Epub 2024 Mar 19.
8
Innate Immune Responses to Highly Pathogenic Coronaviruses and Other Significant Respiratory Viral Infections.
Front Immunol. 2020 Aug 18;11:1979. doi: 10.3389/fimmu.2020.01979. eCollection 2020.
9
Innate immunity: the first line of defense against SARS-CoV-2.
Nat Immunol. 2022 Feb;23(2):165-176. doi: 10.1038/s41590-021-01091-0. Epub 2022 Feb 1.
10
Differences and similarities between innate immune evasion strategies of human coronaviruses.
Curr Opin Microbiol. 2024 Jun;79:102466. doi: 10.1016/j.mib.2024.102466. Epub 2024 Mar 30.

引用本文的文献

2
Advanced nanotherapies for precision treatment of inflammatory lung diseases.
Bioact Mater. 2025 Jul 20;53:329-365. doi: 10.1016/j.bioactmat.2025.07.028. eCollection 2025 Nov.
5
Acute lung injury induced by recombinant SARS-CoV-2 spike protein subunit S1 in mice.
Respir Res. 2025 Feb 19;26(1):59. doi: 10.1186/s12931-025-03143-7.
6
Bronchoalveolar lavage single-cell transcriptomics reveals immune dysregulations driving COVID-19 severity.
PLoS One. 2025 Feb 10;20(2):e0309880. doi: 10.1371/journal.pone.0309880. eCollection 2025.

本文引用的文献

1
NLRP12-PANoptosome activates PANoptosis and pathology in response to heme and PAMPs.
Cell. 2023 Jun 22;186(13):2783-2801.e20. doi: 10.1016/j.cell.2023.05.005. Epub 2023 Jun 1.
2
GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19.
Nature. 2023 May;617(7962):764-768. doi: 10.1038/s41586-023-06034-3. Epub 2023 May 17.
3
Bat ASC2 suppresses inflammasomes and ameliorates inflammatory diseases.
Cell. 2023 May 11;186(10):2144-2159.e22. doi: 10.1016/j.cell.2023.03.036.
5
Interferon-dependent signaling is critical for viral clearance in airway neutrophils.
JCI Insight. 2023 May 22;8(10):e167042. doi: 10.1172/jci.insight.167042.
8
SARS-CoV-2 Spike protein induces TLR4-mediated long-term cognitive dysfunction recapitulating post-COVID-19 syndrome in mice.
Cell Rep. 2023 Mar 28;42(3):112189. doi: 10.1016/j.celrep.2023.112189. Epub 2023 Feb 17.
9
Inherited and acquired errors of type I interferon immunity govern susceptibility to COVID-19 and multisystem inflammatory syndrome in children.
J Allergy Clin Immunol. 2023 Apr;151(4):832-840. doi: 10.1016/j.jaci.2023.02.003. Epub 2023 Feb 24.
10
SARS-CoV-2 infection of intestinal epithelia cells sensed by RIG-I and DHX-15 evokes innate immune response and immune cross-talk.
Front Cell Infect Microbiol. 2023 Feb 7;12:1035711. doi: 10.3389/fcimb.2022.1035711. eCollection 2022.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验